Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
Isidori AM, Cornacchione M, Barbagallo F, Di Grazia A, Barrios F, Fassina L, Monaco L, Giannetta E, Gianfrilli D, Garofalo S, Zhang X, Chen X, Xiang YK, Lenzi A, Pellegrini M, Naro F.
Isidori AM, et al. Among authors: naro f.
Cardiovasc Res. 2015 Jun 1;106(3):408-20. doi: 10.1093/cvr/cvv123. Epub 2015 Apr 7.
Cardiovasc Res. 2015.
PMID: 25852085